Disorders such as Gorham-Stout disease (GSD), kaposiform lymphangiomatosis (KLA), central conducting lymphatic anomaly (CCLA), and generalized lymphatic anomaly (GLA) have been linked to alterations in the RAS/RAF/MEK/ERK signaling pathway [5,13]. Here, MAP2K7 is linked to diffuse lymphatic malformation.